CHARACTERIZATION OF MOUSE UROTHELIAL CELL-LINES IN DIFFERENT PHASES OF TRANSITIONAL-CELL CARCINOGENESIS

被引:12
作者
DEBOER, WI [1 ]
REBEL, JMJ [1 ]
FOEKENS, JA [1 ]
VERMEY, M [1 ]
VANDERKWAST, TH [1 ]
机构
[1] DR DANIEL DEN HOED CANC CTR, DEPT BIOCHEM, ROTTERDAM, NETHERLANDS
关键词
D O I
10.1002/ijc.2910540627
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Altered cellular responsiveness to growth factors is one of the factors involved in carcinogenesis. In order to study the role of growth factors in transitional-cell carcinogenesis, we established 3 urothelial cell lines from normal mouse urothelium, designated g/G, NUC-5 and NUC-1. These cell lines were studied by light and transmission electron microscopy, karyotyping, grafting in syngeneic mice, growth-factor response in vitro under serum-free conditions, and EGF receptor expression. In the presence of insulin or insulin-like growth factors I and II, proliferation of the non-tumorigenic DNA-tetraploid g/G and DNA aneuploid NUC-5 cells is stimulated by EGF, TGFalpha, bFGF and aFGF. This stimulation can be abolished in g/G but not in NUC-5 cells by simultaneous addition of TGFbeta. Proliferation of g/G and NUC-5 cells can also be stimulated by PDGF-AA. The spindle-cell-like NUC-I cells are DNA aneuploid and tumorigenic in syngeneic mice; they express low levels of EGF receptors and their autonomous proliferation is only affected by insulin or insulin-like growth factors. Each of these cell lines seems to reflect a different phase in transitional-cell carcinogenesis: g/G cells have gained immortality, have become tetraploid, but are non-tumorigenic and growth-factor-dependent. NUC-5 cells have become aneuploid, have a growth-factor responsiveness different from that of normal epithelial cells, but are still non-tumorigenic. NUC-I cells are aneuploid, tumorigenic, and growth-factor-independent. These urothelial cell lines provide a suitable tool for further studies in transitional-cell carcinogenesis. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:1022 / 1027
页数:6
相关论文
共 33 条
[1]   GROWTH-FACTORS AND CANCER [J].
AARONSON, SA .
SCIENCE, 1991, 254 (5035) :1146-1153
[2]   MALIGNANT EPITHELIAL-CELLS IN PRIMARY HUMAN LUNG CARCINOMAS COEXPRESS INVIVO PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND PDGF RECEPTOR MESSENGER-RNAS AND THEIR PROTEIN PRODUCTS [J].
ANTONIADES, HN ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
OHARA, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3942-3946
[3]   PROGNOSTIC FACTORS IN PATIENTS WITH PRIMARY TRANSITIONAL CELL-CARCINOMA OF THE UPPER URINARY-TRACT [J].
BADALAMENT, RA ;
OTOOLE, RV ;
KENWORTHY, P ;
YOUNG, DC ;
KEYHANIROFAGHA, S ;
SIMON, J ;
PEREZ, JF ;
DRAGO, JR .
JOURNAL OF UROLOGY, 1990, 144 (04) :859-863
[4]   HYDROXYAPATITE ASSAY TO MEASURE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN PRIMARY BREAST-TUMORS [J].
BENRAAD, TJ ;
FOEKENS, JA .
ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 :272-273
[5]   TRANSFORMING GROWTH-FACTOR-BETA INDUCES PLATELET-DERIVED GROWTH-FACTOR (PDGF) MESSENGER-RNA AND PDGF SECRETION WHILE INHIBITING GROWTH IN NORMAL HUMAN MAMMARY EPITHELIAL-CELLS [J].
BRONZERT, DA ;
BATES, SE ;
SHERIDAN, JP ;
LINDSEY, R ;
VALVERIUS, EM ;
STAMPFER, MR ;
LIPPMAN, ME ;
DICKSON, RB .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (07) :981-989
[6]  
BURHOLT DR, 1989, CANCER RES, V49, P3355
[7]  
CARPENTER G, 1985, J CELL SCI, P1
[8]  
CHODAK GW, 1988, CANCER RES, V48, P2083
[9]  
CHODAK GW, 1986, CANCER RES, V46, P5507
[10]  
COWELL JK, 1982, JNCI-J NATL CANCER I, V69, P425